Araştırma Makalesi
BibTex RIS Kaynak Göster

LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI

Yıl 2024, Cilt: 25 Sayı: 1 - OCAK 2024 SAYISI, 111 - 116, 17.01.2024
https://doi.org/10.18229/kocatepetip.1277018

Öz

AMAÇ: Lenfödem (LÖ) tanısı ile takip edilen hastalarda tamamlayıcı ve alternatif tedavi (TAT) kullanım sıklığının, türünün, bilgi kaynağının, kullanma nedeninin, algılanan yararın ve kullanan grubun özelliklerinin belirlenmesi.
GEREÇ VE YÖNTEM: Çalışmaya meme kanseri ile ilişkili LÖ tanısı ile takip edilmekte olan, 20-90 yaşları arasında 100 hasta dahil edildi. Hastaların sosyodemografik özellikleri, kemoterapi ve radyoterapi seans sayıları ve kullanılan medikal tedavileri yüz yüze görüşme yöntemi ile sorgulandı. Ayrıca hastalardan ‘Meme Kanserine Bağlı Lenfödem Tanılı Hastalarda TAT Kullanım Sıklığı’ başlıklı soru formunu doldurmaları istendi.
BULGULAR: Ortalama yaşları 54.6± 9.3 yıl olan hastaların en az bir TAT yöntemi kullanma oranı %77.0 olarak saptandı . TAT yöntemi olarak en çok masajın (n=40) ve dua etmenin (n=38) tercih edildiği saptandı. Bitki kullanan hasta sayısı 12 idi. Hastaların %48.2'si kullanmaya kendisinin karar verdiğini, %19.2'sinin ise doktor tavsiyesi ile TAT kullanmaya başladığını ifade etti. Doktor tavsiyesi ile TAT kullanan hastalarda tercih edilen yöntemler sırasıyla; kinesiotaping uygulaması (n=24), düşük güçlü lazer uygulaması (n=19) ve yoga (n=7) idi. Çalışmamızda TAT kullanan hastaların sadece %35'inin bu konuda doktoruna bilgi verdiği görüldü.
SONUÇ: LÖ hastalarının yaklaşık yarısının TAT kullanımı ile ilgili sağlık çalışanlarına bilgi vermediği, bir çok hastanın tanı alır almaz veya tedavileri halen devam etmekte iken bu yöntemleri kullandığı belirlenmiştir. Özellikle LÖ ile ilgilenen klinisyenlerin rutin değerlendirme içinde yer alarak TAT yöntemlerini dökümente etmeleri ve TAT yöntemlerinin potansiyel zararları hakkında bilgi sahibi olup hastaları doğru yönlendirmeleri gerekmektedir.

Destekleyen Kurum

Yoktur

Kaynakça

  • 1. Morris C, Wonders KY. Concise review on the safety of exercise on symptoms of lymphedema. World J Clin Oncol. 2015;6(4):43–4.
  • 2. Rodrick JR, Poage E, Wanchai A, Stewart BR, Cormier JN, Armer JM. Complementary, alternative, and other noncomplete decongestive therapy treatment methods in the management of lymphedema: A systematic search and review. PMR. 2014;6(3):250–74.
  • 3. Vignes S, Blanchard M, Arrault M, Porcher R. Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4. Gynecol Oncol. 2013;131(1):127–30.
  • 4. Koithan M. Introducing Complementary and Alternative Therapies. J Nurse Pract. 2010; 5(1): 18–20.
  • 5. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: A systematic review. Clin J Oncol Nurs. 2010;14(4):45-55.
  • 6. Davies C, Levenhagen K, Ryans K, Perdomo M, Gilchrist L. Interventions for breast cancer-related lymphedema: Clinical practice guideline from the academy of oncologic physical therapy of APTA. Phys Ther. 2020;100(7):1163–79.
  • 7. Wanchai A, Armer JM, Stewart BR. Complementary and Alternative Medicine and Lymphedema. Semin Oncol Nurs . 2013;29(1):41–9.
  • 8. Finnane A, Liu Y, Battistutta D, Janda M, Hayes SC. Lymphedema after breast or gynecological cancer: Use and effectiveness of mainstream and complementary therapies. J Altern Complement Med. 2011;17(9):867–9.
  • 9. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol. 2000;18(13):2515–21.
  • 10. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.
  • 11. Fremd C, Hack CC, Schneeweiss A, et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet. 2017;295(5):1239–45.
  • 12. Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: Prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10(7):542–8.
  • 13. Münstedt K, Vogt T, Rabanus ME, Hübner J. Wishes and beliefs of cancer patients regarding counseling on integrative medicine. Breast Care. 2014;9(6):416–20.
  • 14. Trimborn A, Senf B, Muenstedt K, et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol. 2013;24(10):2641–5.
  • 15. Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143–51.
  • 16. Kasawara KT, Mapa JMR, Ferreira V, et al. Effects of Kinesio Taping on breast cancer-related lymphedema: A meta-analysis in clinical trials. Physiother Theory Pract. 2018;34(5):337–45.
  • 17. Smoot B, Chiavola-Larson L, Lee J, Manibusan H, Allen DD. Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis. J Cancer Surviv. 2015;9(2):287–304.
  • 18. Loudon A, Barnett T, Piller N, Immink MA, Visentin D, Williams AD. The effects of yoga on shoulder and spinal actions for women with breast cancer-related lymphoedema of the arm: A randomised controlled pilot study. BMC Complement Altern Med. 2016;16 (1).
  • 19. Pasyar N, Barshan Tashnizi N, Mansouri P, Tahmasebi S. Effect of yoga exercise on the quality of life and upper extremity volume among women with breast cancer related lymphedema: A pilot study. Eur J Oncol Nurs. 2019;42:103–9.
  • 20. Wei CW, Wu YC, Chen PY, Chen PE, Chi CC, Tung TH. Effectiveness of Yoga Interventions in Breast Cancer- Related lymphedema: A systematic review. Complement Ther Clin Pract. 2019;36:49–55.

THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN PATIENTS WITH LYMPHEDEMA

Yıl 2024, Cilt: 25 Sayı: 1 - OCAK 2024 SAYISI, 111 - 116, 17.01.2024
https://doi.org/10.18229/kocatepetip.1277018

Öz

OBJECTIVE: Determining the frequency, type, source of information, reason for use, perceived benefit, and characteristics of the user group of complementary and alternative therapy (CAM) in patients with lymphedema (LE).
MATERIAL AND METHODS: A total of 100 patients aged 20-90 years, who were being followed up with the diagnosis of breast cancer-related LE, were included in the study. Sociodemographic characteristics of the patients, number of chemotherapy and radiotherapy sessions and medical treatments were questioned by face-to-face interview method. In addition, patients were asked to fill out the question form titled ‘Frequency of CAM Use in Patients Diagnosed with Lymphedema Due to Breast Cancer’.
RESULTS: In patients with the mean age of 54.6± 9.3 years, 77.0% used at least one CAM method. It was determined that massage (n=40) and praying (n=38) were mostly preferred as CAM methods. The utilization rate of the plant was 12. It was discovered that 48.2% of the patients chose to use it on their own, while 19.2% began using it on the advice of a doctor. The preferred methods in patients using CAM with the advice of a doctor are respectively; kinesiotaping application (n=24), low level laser application (n=19) and yoga (n=7). In our study, it was observed that only 35% of the patients using CAM informed their doctor about this issue.
CONCLUSIONS: It has been determined that about half of LE patients do not inform health professionals about the use of CAM, and many patients use these methods as soon as they receive a diagnosis or while their treatment is still ongoing. Clinicians, especially those interested in LE, should document CAM methods by taking part in routine evaluation and have information about the potential harms of CAM methods and guide patients correctly.

Kaynakça

  • 1. Morris C, Wonders KY. Concise review on the safety of exercise on symptoms of lymphedema. World J Clin Oncol. 2015;6(4):43–4.
  • 2. Rodrick JR, Poage E, Wanchai A, Stewart BR, Cormier JN, Armer JM. Complementary, alternative, and other noncomplete decongestive therapy treatment methods in the management of lymphedema: A systematic search and review. PMR. 2014;6(3):250–74.
  • 3. Vignes S, Blanchard M, Arrault M, Porcher R. Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4. Gynecol Oncol. 2013;131(1):127–30.
  • 4. Koithan M. Introducing Complementary and Alternative Therapies. J Nurse Pract. 2010; 5(1): 18–20.
  • 5. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: A systematic review. Clin J Oncol Nurs. 2010;14(4):45-55.
  • 6. Davies C, Levenhagen K, Ryans K, Perdomo M, Gilchrist L. Interventions for breast cancer-related lymphedema: Clinical practice guideline from the academy of oncologic physical therapy of APTA. Phys Ther. 2020;100(7):1163–79.
  • 7. Wanchai A, Armer JM, Stewart BR. Complementary and Alternative Medicine and Lymphedema. Semin Oncol Nurs . 2013;29(1):41–9.
  • 8. Finnane A, Liu Y, Battistutta D, Janda M, Hayes SC. Lymphedema after breast or gynecological cancer: Use and effectiveness of mainstream and complementary therapies. J Altern Complement Med. 2011;17(9):867–9.
  • 9. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol. 2000;18(13):2515–21.
  • 10. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.
  • 11. Fremd C, Hack CC, Schneeweiss A, et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet. 2017;295(5):1239–45.
  • 12. Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: Prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10(7):542–8.
  • 13. Münstedt K, Vogt T, Rabanus ME, Hübner J. Wishes and beliefs of cancer patients regarding counseling on integrative medicine. Breast Care. 2014;9(6):416–20.
  • 14. Trimborn A, Senf B, Muenstedt K, et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol. 2013;24(10):2641–5.
  • 15. Schofield P, Diggens J, Charleson C, Marigliani R, Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143–51.
  • 16. Kasawara KT, Mapa JMR, Ferreira V, et al. Effects of Kinesio Taping on breast cancer-related lymphedema: A meta-analysis in clinical trials. Physiother Theory Pract. 2018;34(5):337–45.
  • 17. Smoot B, Chiavola-Larson L, Lee J, Manibusan H, Allen DD. Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis. J Cancer Surviv. 2015;9(2):287–304.
  • 18. Loudon A, Barnett T, Piller N, Immink MA, Visentin D, Williams AD. The effects of yoga on shoulder and spinal actions for women with breast cancer-related lymphoedema of the arm: A randomised controlled pilot study. BMC Complement Altern Med. 2016;16 (1).
  • 19. Pasyar N, Barshan Tashnizi N, Mansouri P, Tahmasebi S. Effect of yoga exercise on the quality of life and upper extremity volume among women with breast cancer related lymphedema: A pilot study. Eur J Oncol Nurs. 2019;42:103–9.
  • 20. Wei CW, Wu YC, Chen PY, Chen PE, Chi CC, Tung TH. Effectiveness of Yoga Interventions in Breast Cancer- Related lymphedema: A systematic review. Complement Ther Clin Pract. 2019;36:49–55.
Toplam 20 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Klinik Tıp Bilimleri
Bölüm Makaleler-Araştırma Yazıları
Yazarlar

Hilal Yeşil 0000-0002-8291-1515

Sibel Eyigör 0000-0002-9781-2712

Nuran Eyvaz 0000-0001-7810-9004

Menekse İnbat 0000-0003-3080-1389

Yayımlanma Tarihi 17 Ocak 2024
Kabul Tarihi 20 Haziran 2023
Yayımlandığı Sayı Yıl 2024 Cilt: 25 Sayı: 1 - OCAK 2024 SAYISI

Kaynak Göster

APA Yeşil, H., Eyigör, S., Eyvaz, N., İnbat, M. (2024). LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI. Kocatepe Tıp Dergisi, 25(1), 111-116. https://doi.org/10.18229/kocatepetip.1277018
AMA Yeşil H, Eyigör S, Eyvaz N, İnbat M. LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI. KTD. Ocak 2024;25(1):111-116. doi:10.18229/kocatepetip.1277018
Chicago Yeşil, Hilal, Sibel Eyigör, Nuran Eyvaz, ve Menekse İnbat. “LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI”. Kocatepe Tıp Dergisi 25, sy. 1 (Ocak 2024): 111-16. https://doi.org/10.18229/kocatepetip.1277018.
EndNote Yeşil H, Eyigör S, Eyvaz N, İnbat M (01 Ocak 2024) LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI. Kocatepe Tıp Dergisi 25 1 111–116.
IEEE H. Yeşil, S. Eyigör, N. Eyvaz, ve M. İnbat, “LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI”, KTD, c. 25, sy. 1, ss. 111–116, 2024, doi: 10.18229/kocatepetip.1277018.
ISNAD Yeşil, Hilal vd. “LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI”. Kocatepe Tıp Dergisi 25/1 (Ocak 2024), 111-116. https://doi.org/10.18229/kocatepetip.1277018.
JAMA Yeşil H, Eyigör S, Eyvaz N, İnbat M. LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI. KTD. 2024;25:111–116.
MLA Yeşil, Hilal vd. “LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI”. Kocatepe Tıp Dergisi, c. 25, sy. 1, 2024, ss. 111-6, doi:10.18229/kocatepetip.1277018.
Vancouver Yeşil H, Eyigör S, Eyvaz N, İnbat M. LENFÖDEM TANILI HASTALARDA GELENEKSEL VE TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI. KTD. 2024;25(1):111-6.

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.